Marco Ruella, MD, based in Philadelphia, PA, is a hematologist specializing in treating patients aged 18 and up. As the Scientific Director of the Lymphoma Program at Penn Medicine, Dr. Ruella focuses on hematologic malignancies such as lymphoma, leukemia, and myeloma.
With expertise in chimeric antigen receptor T cell (CAR-T) immunotherapies, Dr. Ruella's research aims to understand relapse mechanisms and develop innovative combined immunotherapies for refractory leukemia and lymphoma. His work in targeted immunotherapies for hematological cancers has earned him numerous awards and honors in the field.
Generated from their business information